Innovation Pharmaceuticals Inc (IPIX)

[BonelessCat]

B-OM isn’t on a shelf. It is very active. They are now waiting for a BTD Approval while currently formulating and packaging. Even without the BTD someone will be interested in the only effective treatment for OM that delays onset and severity, reduces time of severity and prevents severe OM in over 40 percent of all head and neck cancer patents.